Fig. 5From: Upregulated NLGN1 predicts poor survival in colorectal cancerIncreased NLGN1 expression predicted worse overall survival in CRC patients from A GSE24551, B GSE39582, and C TCGA. Higher NLGN1 levels were associated with significantly decreased recurrence-free survival rates in D GSE39582 and disease-free survival rates in E patients in our centreBack to article page